Skip to main content

Table 4 Predicted target of metformin via PharmMapper and its docking value with different targets

From: Multiple therapeutic effect of endothelial progenitor cell regulated by drugs in diabetes and diabetes related disorder

Metformin

S. no.

Protein name

EST. free energy of binding (kcal/mol)

EST. inhibition constant, Ki (mM)

vdW+ Hbond+ desolv energy (kcal/mol)

Electrostatic energy (kcal/mol)

Total intermol. energy (kcal/mol)

Frequency (%)

Interact. surface

1.

Beta secretase

−5.54

0.086

−2.56

−2.98

−5.54

80

346.622

2.

HSP 90

−4.09

1.01

−3.58

−0.50

−4.09

30

365.345

3.

Fructose-1,6-bisphosphatase

−2.93

7.15

−1.54

−1.39

−2.93

20

219.69

4.

Neuraminidase

+0.03

–

+0.00

+0.03

+0.03

30

17,111.543

5.

CDK 2

−3.28

3.97

−1.42

−1.86

−3.28

100

269.215

6.

Glutathione S transferase

−0.03

944.98

+0.00

−0.03

−0.03

40

10,475.752

7

eNOS

−6.8

0.01

−3.68

−3.13

−6.82

100

419.151